Merger Notification - Announcement according to § 10 Cartel Act
Cheplapharm Arzneimittel GmbH; TPI; Braun Beteiligungs GmbH
BWB/Z-5093
On 11.11.2020 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
Cheplapharm Arzneimittel GmbH will acquire several trademarks, patents and other intellectual property rights from Takeda Pharmaceuticals International AG.
Affected area of business: trade with pharmaceutical substances.
Industry sector: C - Verarbeitendes Gewerbe/Herstellung von Waren
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 09.12.2020.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 10.12.2020 .